MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Machine Learning Prediction of Motor Score Reduction following DBS Surgery in PD

    C. Raimondo, C. Wu, M. Alizadeh (Philadelphia, USA)

    Objective: This study investigates several machine learning methods for predicting motor score reduction following DBS surgery in patients with PD using multi-modal feature selection. Background:…
  • 2023 International Congress

    Characteristics of cases in which stimulation was programmed for multiple targets in deep brain stimulation therapy for Parkinson’s disease.

    K. Kimura, H. Kishida, N. Ueda, T. Kawasaki, F. Tanaka (Yokohama, Japan)

    Objective: To clarify the the clinical background of Parkinson's disease patients with DBS who received multiple stimulus targets. Background: Deep brain stimulation (DBS) is an…
  • 2022 International Congress

    A Literature Review: Effectiveness of Transcranial Direct Current Stimulation on gait speed and freezing of gait in patients with Parkinson’s disease

    T. Mok (hong kong, Hong Kong)

    Objective: The objective of this review is to update evidence on benefits of tDCS on gait speed and freezing of gait (FOG) for PD patients…
  • 2022 International Congress

    Cognitive and Functional Trajectories in Prediagnostic Parkinson’s Disease

    M. Bock, E. Vittinghoff, A. Bahorik, Y. Leng, K. Yaffe (San Francisco, USA)

    Objective: To describe prediagnostic cognitive and functional trajectories in Parkinson’s Disease (PD). Background: Cognitive and functional decline is typically considered a late manifestation of PD.…
  • 2022 International Congress

    Epidemiologic And Clinical Features Of Psychiatric Disorders In Patients With Parkinson’s Disease – A Retrospective Cohort Study

    O. Koniashvili, G. Khachiashvili, L. Gabunia (Tbilisi, Georgia)

    Objective: We aimed to assess the average duration of Parkinson's disease at the time patient was diagnosed with specific neuropsychiatric disturbance, to study their prevalence…
  • 2022 International Congress

    Long-term efficacy of unilateral high-intensity focused ultrasound subthalamotomy for Parkinson’s Disease

    R. Martínez-Fernández, E. Natera-Villalba, J. Máñez-Miró, R. Rodríguez-Rojas, M. Del Alamo, J. Pineda-Pardo, I. Obeso, F. Hernández-Fernández, C. Gasca-Salas, M. Matarazzo, L. Vela, F. Alonso-Frech, J. Obeso (Móstoles, Madrid, Spain)

    Objective: To explore the long-term safety and efficacy of focused ultrasound subthalamotomy (FUS-STN). Background: Unilateral MRI-guided high-intensity FUS-STN improves motor signs of Parkinson’s disease (PD) [1]…
  • 2022 International Congress

    Caregiver burden and quality of life in late stage Parkinson’s disease

    K. Rosqvist, A. Schrag, P. Odin (Lund, Sweden)

    Objective: To describe and assess factors associated with informal caregiver quality of life (QoL) in late stage Parkinson’s disease (PD). Background: In the late stage…
  • 2022 International Congress

    Effect of levodopa-carbidopa intestinal gel on lower urinary tract symptoms in Parkinson’s disease: an Urodynamic study

    D. Rinaldi, O. Voglino, A. Tubaro, FE. Pontieri (rome, Italy)

    Objective: Here we report urodynamic results before and six months after LCIG treatment in PD patients suffering from LUTS. Background: Dopaminergic transmission plays a key…
  • 2022 International Congress

    Safety of opicapone after 5 years of post-marketing experience worldwide

    L. Guedes, J. Graça, M. Sampaio, M. Vieira, F. Rocha, H. Gama (Coronado, Portugal)

    Objective: To review the safety data of opicapone (OPC) after five years of marketing experience worldwide Background: OPC is a once-daily catechol-O-methyltransferase (COMT) inhibitor proven…
  • 2022 International Congress

    The REONPARK (REgistry of the use of COMT-inhibitors in the maNagement of patients with PARKinson’s disease in Spain who present early motor fluctuations) study: rationale and design of a national, multicentre and prospective study

    L. Lopez-Manzanares, E. Casas-Peña, I. Muro-Garcia, I. Caballero, F. Almeida, I. Tegel, P. Sarasa (Madrid, Spain)

    Objective: To describe the real-world use of catechol-O-methyltransferase (COMT) inhibitors add on to levodopa/dopa decarboxylase inhibitor (DDCI) in patients with Parkinson’s disease (PD) suffering from…
  • « Previous Page
  • 1
  • …
  • 406
  • 407
  • 408
  • 409
  • 410
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley